Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.600
+0.100 (4.00%)
Aug 27, 2026, 3:44 PM HKT
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.37 billion as of August 27, 2026. Its market cap has decreased by -35.28% in one year.
Market Cap
1.37B
Enterprise Value
628.01M
Revenue
35.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
ChartMarket Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.37B, a decrease of -82.10%. That is a compound annual growth rate of -27.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.43B | -12.04% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.97B |
| Guangzhou Innogen Pharmaceutical Group | 1.86B |
| HighTide Therapeutics | 1.84B |
| Mabpharm | 1.77B |
| SinoMab BioScience | 1.54B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.47B |
| Beijing Biostar Pharmaceuticals | 1.24B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.23B |